No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
INCY Incyte
- 68.840
- +1.780+2.65%
Close Dec 20 16:00 ET
- 68.820
- -0.020-0.03%
Post 16:36 ET
13.26BMarket Cap764.89P/E (TTM)
69.110High66.890Low6.81MVolume66.890Open67.060Pre Close467.15MTurnover4.24%Turnover Ratio25.98P/E (Static)192.65MShares83.95052wk High4.18P/B11.05BFloat Cap50.35052wk Low--Dividend TTM160.50MShs Float153.150Historical High--Div YieldTTM3.31%Amplitude1.850Historical Low68.643Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Wells Fargo Maintains Incyte(INCY.US) With Hold Rating, Raises Target Price to $70
Incyte Price Target Raised to $70 From $68 at Wells Fargo
The Analyst Verdict: Incyte In The Eyes Of 15 Experts
Wells Fargo Adjusts Incyte's Price Target to $70 From $68, Keeps Equalweight Rating
Analysts Offer Insights on Healthcare Companies: Century Therapeutics (IPSC), Incyte (INCY) and Bicycle Therapeutics (BCYC)
Incyte Analyst Ratings
Heat List
US
Overall
Symbol
Price
% Chg
No Data
